M16-100
ClinicalTrials.gov NCT03518034
Research payments
$44,474,580
Through program year 2020, $44,474,580 in research payments was reported against M16-100, across 7,945 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03518034
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $15,942,956 | 4,093 |
| 2019 | Research | $28,531,624 | 3,852 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kwabena Ayesu Orlando, FL Named on 218 payments
- Brian MacGillivray San Antonio, TX Named on 155 payments
- Cynthia Brinson Austin, TX Named on 117 payments
- Allan Dinnerstein Fort Stewart, GA Named on 89 payments
- Kanakadurga Govindaraju Kyle, TX Named on 79 payments
- Derek Lejeune Euless, TX Named on 77 payments
- Stephen Plantholt Baltimore, MD Named on 72 payments
- Jerome Daniel Richmond, VA Named on 69 payments
- Arvind Krishna Canton, OH Named on 67 payments
- Steven Leichter Columbus, GA Named on 66 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.